Earth Science Tech, Inc. (OTC: ETST) has announced its fiscal first-quarter 2027 financial results, revealing a 57% year-over-year increase in net income to $715,697. The company's revenue reached $9.0 million, up 3% from the prior-year period, while gross profit climbed to $6.3 million. Operating cash flow more than doubled to $707,131, and total assets increased to $10.4 million. Diluted earnings per share improved to $0.003 from $0.001, and the company repurchased and retired over 3.7 million common shares during the quarter without incurring additional debt.
These results underscore Earth Science Tech's robust operational performance and its ability to generate shareholder value. The company highlighted that all key operating subsidiaries remained profitable, and it continued to expand the licensing footprint of its compounding pharmacy operations across the United States. Management is also evaluating opportunities to broaden its telehealth and pharmacy fulfillment platforms, positioning the company for further growth.
The company's strategic initiatives are set to be discussed at its annual shareholder meeting on Aug. 31, 2026, where investors will vote on proposals including the cancellation of the company's Series B Preferred Stock. Additionally, management will provide updates on a potential exchange uplisting aimed at improving liquidity and market visibility. These moves reflect Earth Science Tech's commitment to enhancing its corporate structure and increasing shareholder value.
Earth Science Tech operates as a diversified holding company focused on the health and wellness sector, with a strategy to build a vertically integrated healthcare platform. This platform combines compounding pharmacy operations, telemedicine platforms, clinical support, and direct-to-patient fulfillment. The company's healthcare operations are supported by investments in real estate and asset management activities, as well as a consumer products business. The core of its value proposition is the seamless integration of patient care, from consultation to fulfillment, achieved through the synergy of specialized subsidiaries.
The positive financial results and strategic focus come at a time when the healthcare industry is evolving, with increasing demand for integrated and accessible care solutions. Earth Science Tech's ability to grow its net income and cash flow while reducing share count demonstrates strong execution and prudent capital management. The potential uplisting could attract a broader investor base and enhance the company's visibility in the financial markets.
For more information on Earth Science Tech and its latest news, visit the company's newsroom at https://ibn.fm/ETST. To view the full press release, visit https://ibn.fm/WHicW.
